Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

M&A/IPOs

 

Medanta’s parent IPOs

Global Health Ltd, the parent company of Indian hospital chain Medanta, closed subscription for its IPO on Monday, with a valuation of 22,060m rupees ($274m). The share price has been set at 319 Rs ($3.96). The IPO will consist of new shares worth 5,000m Rs ($62m), and an offer-for-sale of up to 50.8m Rs ($0.63m) worth of shares.
November 11, 2022

Deals postponed and at risk

Deal flow is slowing rapidly. HBI hears CVC has postponed the sale of Finland-based occupational and outpatient specialist Mehilainen. The Trilantic sale of Berlin-based mental health specialist Oberberg, and the Nordic sale of European Dental Group are both at risk too. But we hear that the sales of ophtha group Optegra and diagnostic group Rad-X are likely to proceed.
November 4, 2022

Care Hospitals target of $1bn+ bidding war

Indian hospital chain Care Hospitals is the subject of a US$1bn+ bidding war between PE firm KKR, Singaporean state holding company Temasek Holdings, and Indian hospital chain Max Healthcare.
November 4, 2022

Optegra for sale

UK-based ophthalmology group Optegra is for sale, with three groups through to the second round. HBI speaks with three sources to find out more.
October 28, 2022

Is Elliott stake a step towards Helios breakoff?

American investment management firm Elliott has taken a minority stake in Fresenius Helios, the largest hospital group in Europe by revenue. The move prompts fresh questions about Fresenius' new CEO's intentions for the company.
October 28, 2022

CBPE Capital buys rapidly expanding UK varicose vein treatment chain

Dermatology is hot right now. UK private equity firm Palatine has sold its stake in Veincentre, the UK’s largest chain varicose vein treatment provider, to CBPE Capital (another UK private equity group). This follows the acquisition of Dutch dermatology group Mauritskliniek last month.
October 21, 2022

FutureLife enters Spain and Italy

FutureLife, the Czech Republic-based fertility company, has entered Spain and Italy with its latest acquisition. Owned by PE companies CVC and Hartenberg holding, the group has acquired Institut Marquès (IM), an assisted reproduction company based in Barcelona with clinics in Spain and Italy.
October 21, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us